![]() |
Bioventus Durham, North Carolina Headquartered in Durham, N.C., Bioventus is Smith & Nephew’s former Biologics Division/Clinical Therapies business that generates about 250 million dollars in revenue annually on a worldwide basis. The product line includes the EXOGEN® Ultrasound Bone Healing System, and hyaluronic acid joint fluid therapy products, SUPARTZ® and DUROLANE®, which treat the symptoms of osteoarthritis. These innovative products provide clinical benefits to patients and cost savings to payers by delaying or eliminating the need for knee surgery. In the case of bone stimulation, expensive follow-on procedures for bone fractures which do not heal are avoided. Contact: Guy P. Nohra |
![]() |
Carbylan BioSurgery, Inc. Palo Alto, CA Carbylan BioSurgery is developing bioresponsive medical products for osteoarthritis and chronic rhinosinusitus. The Company’s device/drug combination products are based on chemically engineered polymers of hyaluronic acid. Carbylan’s proprietary technology enables delivery for biomaterial-based medical devices as injectable liquids that self-polymerize inside the body to form therapeutic implants that covalently bind to tissues at the target delivery site. Contact: Guy P. Nohra |
![]() |
Insulet Corporation Bedford, MA Insulet is commercializing the OmniPod Insulin Management System for diabetes patients. Nasdaq: PODD |
![]() |
Nanomix, Inc. Emeryville, CA Nanomix is a leading nanotechnology company launching a portfolio of devices based on Sensation™ detection technology. These scaleable, nanoelectronic devices use ultra-sensitive carbon nanotube sensing elements combined with proprietary chemistries. These devices can be deployed across a broad range of industrial and medical applications where the attributes of nanodetection technology - low power consumption, small form factor, and high sensitivity offer significant performance advantages and enable unprecedented access to critical information. Contact: Garrett Gruener |
![]() |
PneumRx, Inc. Mountain View, CA PneumRx is developing devices to address the unmet clinical needs in the interventional pulmonary/thoracic surgery market. Contact: Guy P. Nohra |
![]() |
USGI Medical, Inc. San Clemente, CA USGI Medical is focused on the development of technologies to enable advanced therapeutic procedures to be performed through the natural passageways of the GI tract. Contact: Guy P. Nohra |
![]() |
Vertiflex, Inc. Carlsbad, CA Vertiflex is developing a line of proprietary products that will have substantial benefits for both patients and spine surgeons. Vertiflex products are focused in the area of motion preservation with an emphasis on minimally invasive approaches. Contact: Guy P. Nohra |
Medical Technology
Portfolio News
- May 02, 2013
Insulet to Develop New Version of the OmniPod Insulin Pump for Use With Humulin R U-500 Concentrated Insulin for People With Type 2 Diabetes - March 13, 2013
Vertiflex®, Inc. Announces Sale of Certain Non-Core Spinal Implant Technologies to Stryker - February 26, 2013
Medical Device Daily: Product Briefs - PnuemRx, Inc. - February 10, 2013
Nanōmix Initiates Clinical Testing of Point of Care IVD Cardiac Panel - February 06, 2013
Medical Device Daily: Med-Tech Notes - Carbylan BioSurgery, Inc. - January 08, 2013
Vertiflex®, Inc. Announces FDA Clearance of Two Key Additions to Technology Portfolio - December 17, 2012
Medical Device Daily: Insulet Takes Insulin Delivery to Another Level with OmniPod - October 22, 2012
Bioventus Signs Lease for New Memphis Facility - July 31, 2012
Medical Device Daily: France Agrees to Test PneumRx Device







